Erratum: Immunodiagnostic Tests’ Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study (Transplantation Direct (2015) 1 (e12) DOI: 10.1097/TXD.0000000000000520);Immunodiagnostic Tests’ Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study

Transplantation Direct

Volumn 1, Issue 3, 2015, Pages

  Muñoz, Laura ^b,d   Gomila, Aina ^b   Casas, Susana ^a   Castellote, José ^b   Arnan, Montserrat ^c   Rafecas, Antoni ^b   Santin, Miguel ^b,d  

^a HOSPITAL DOS DE MAIG   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85045096108     PISSN: None     EISSN: 23738731     Source Type: Journal    
DOI: 10.1097/TXD.0000000000000524     Document Type: Erratum

References (19)

1. Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40(4):990–1013.
2. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266–1277.
3. Muñoz P, Palomo J, Muñoz R, et al. Tuberculosis in heart transplant recipients. Clin Infect Dis. 1995;21(2):398–402.
4. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009;48(12):1657–1665.
5. Holty JE, Gould MK, Meinke L, et al. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl. 2009;15(8):894–906.
6. Horne DJ, Narita M, Spitters CL, et al. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57(10):1473–1482.
7. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48 (9):1276–1284.
8. Jafri S-M, Singal AG, Kaul D, et al. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl. 2011;17 (3):306–314.
9. Casas S, Muñoz L, Moure R, et al. Comparison of the 2-step tuberculin skin test and the QuantiFERON-TB Gold In-tube for the screening of tuberculosis infection before liver transplantation. Liver Transpl. 2011;17 (10):1205–1211.
10. Kim SH, Lee SO, Park JB, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant. 2011;11(9):1927–1935.
11. Lange B, Vavra M, Kern WV, Wagner D. Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA. Int J Tuberc Lung Dis. 2012;16(4):492–495.
12. Theodoropoulos N, Lanternier F, Rassiwala J, et al. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study. Transpl Infect Dis. 2012;14(1):1–8.
13. Jeong JC, Koo TY, Jeon HJ, et al. Utility of QuantiFERON-TB assay for prediction of tuberculosis development in kidney transplant patients in an intermediate-tuberculosis-burden country: lack of evidence for enhanced prediction for short-term tuberculosis development. Transplant Proc. 2014;46(2):583–587.
14. Moon SM, Lee SO, Choi YS, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15(1):104–109.
15. Generalitat de Catalunya. Departament de salut. Accessed 14/07/2014. http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/Professionals/Temes_de_salut/Tuberculosi/documents/arxius/inf2010tuber.pdf.
16. Sester M, van Leth F, Bruchfeld J, et al. Risk assessment of tuberculosis in immunocompromised patients—a TBNET study. Am J Respir Crit Care Med. 2014;190(10):1168–1176.
17. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state. A meta-analysis. Chest. 2012;142(1):63–75.
18. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45–55.
19. Muñoz L, Santin M. Interferon-γ release assays vs tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review. J Infect. 2013;66(4):381–387.